Drugs in the Pipeline
Imbruvica Under Review for Graft-Versus-Host-Disease
Imbruvica is a first-in-class, oral Bruton's tyrosine kinase (BTK) inhibitor.
Your search for oral corticosteroids returned 2 results
Drugs in the Pipeline
Novel Asthma Biologic Demonstrates Efficacy in Two Phase 3 Studies
AstraZeneca announced that two pivotal Phase 3 registrational trials for benralizumab achieved their primary endpoint, demonstrating significant reductions in the annual asthma exacerbation rate compared to placebo.
